QR kód

Re-evaluating Treatments for Advanced Urothelial Carcinoma Using Restricted Mean Survival Time: A Systematic Review and Network Meta-analysis

Background and objective: The proportional hazards (PH) assumption may not hold for immune checkpoint inhibitor (ICI) trials because of delayed treatment effects. We assessed PH validity in trials of first-line treatment in advanced urothelial carcinoma (UC) and compared treatments using restricted...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shugo Yajima, Wei Chen, Kohei Hirose, Akihiro Hirakawa, Kenji Tanabe, Motohiro Fujiwara, Hiroshi Fukushima, Hajime Tanaka, Hitoshi Masuda, Yasuhisa Fujii, Soichiro Yoshida
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2026-03-01
Edice:European Urology Open Science
Témata:
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2666168326000200
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!